LEVEL 4 C08CA13

Δραστικές

Φάρμακα

  • DRUGBANK - Lercanidipine
  • indication:

    For the treatment of Hypertension, management of angina pectoris and Raynaud's syndrome

  • pharmacology:

  • mechanism:

    By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, Lercanidipine inhibits the influx of extracellular calcium across the myocardial and vascular smooth muscle cell membranes The decrease in intracellular calcium inhibits the contractile processes of the myocardial smooth muscle cells, causing dilation of the coronary and systemic arteries, increased oxygen delivery to the myocardial tissue, decreased total peripheral resistance, decreased systemic blood pressure, and decreased afterload.

  • toxicity:

  • absorprion:

  • halflife:

  • roouteelimination:

  • volumedistribution:

  • clearance: